XML 50 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders Equity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 19, 2021
USD ($)
shares
Jun. 11, 2021
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
D
$ / shares
shares
Apr. 24, 2022
item
shares
Mar. 21, 2022
Dec. 31, 2021
Sep. 30, 2021
May 27, 2021
shares
Jan. 31, 2017
Shareholders' Equity                    
Multiplying factor for exercise of warrants | item         3          
Percentage volume weighted average price of stock times factor must exceed sum of volume weighted average prices of second, third and fourth days before exercise         6.00%          
Conversion price percentage     95.00% 95.00%            
Loss recognized from increase in liability | $     $ 34,049 $ (59,684)            
Proceeds from issuance of common shares, net of issuance costs | $       $ 3,767            
5.10% senior notes due September 2023                    
Shareholders' Equity                    
Interest rate (as a percent)     5.10% 5.10%     5.10%      
0.75% senior exchangeable notes due January 2024                    
Shareholders' Equity                    
Interest rate (as a percent)     0.75% 0.75%   0.75% 0.75% 0.75%   0.75%
5.75% senior notes due February 2025                    
Shareholders' Equity                    
Interest rate (as a percent)     5.75% 5.75%     5.75% 5.75%    
7.25% senior notes due January 2026                    
Shareholders' Equity                    
Interest rate (as a percent)     7.25% 7.25%            
Common Stock Warrants                    
Shareholders' Equity                    
Number of warrants received per common share held                 0.40  
Number of warrants issued   3,200,000                
Number of business day notice period | D       20            
Fair value of outstanding warrants | $     $ 44,700 $ 44,700            
Loss recognized from increase in liability | $     $ (34,000) $ (63,000)            
Warrants outstanding     2,500,000 2,500,000            
Common Stock                    
Shareholders' Equity                    
Shares issued in connection with acquisition of certain development stage technologies in the energy transition space 147,974                  
Value of shares issued in connection with acquisition of certain development stage technologies in the energy transition space | $ $ 12,900                  
Number of shares which may be forfeited under certain conditions 71,280                  
Forfeiture period 2 years                  
Aggregate number of shares issued from the exercise of warrants     1,100,000 1,100,000            
Number of shares which may be purchased by each right     1 1            
Exercise price (in dollars per share) | $ / shares     $ 166.66667 $ 166.66667            
Number of additional securities which may be issued due to the incentive share component         0.333